コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Funding Source: U.S. Department of Veterans Affairs.
2 ancisco, and the U.S. Department of Veterans Affairs.
3 y of Copenhagen, U.S. Department of Veterans Affairs.
4 undation and the U.S. Department of Veterans Affairs.
5 h and Quality; and US Department of Veterans Affairs.
6 role in the natural environment and in human affairs.
7 itutes of Health, and Department of Veterans Affairs.
8 Department of Veterans Affairs.
9 ouncil, Glaxo Wellcome International Medical Affairs.
10 s of Health, and U.S. Department of Veterans Affairs.
11 ed the specialty and its influence on public affairs.
12 ducted using national Department of Veterans Affairs administrative data of patients hospitalized at
15 ment, Academy of Finland, Ministry of Social Affairs and Employment (Netherlands), Economic and Socia
16 ment, Academy of Finland, Ministry of Social Affairs and Employment (Netherlands), US National Instit
17 Funding Source: U.S. Department of Veterans Affairs and Institute for Clinical and Economic Review.
20 rescription-fill data were linked to Veteran Affairs and Medicare encounter files, each person-day of
22 ide a concise review of the current state of affairs and potential future developments in the diagnos
24 using a data set created by linking Veterans Affairs and US Renal Data System information, including
28 ow is Vice President for Global Microbiology Affairs at bioMerieux, Durham, NC, wrote the initial cou
30 rom 2011 to 2013 was performed at a Veterans Affairs-based urology clinic in Brooklyn, New York, amon
35 Michigan Foundation, Department of Veterans Affairs Center for Clinical Management Research, Univers
40 n 2008 were ascertained through the Veterans Affairs Central Cancer Registry and sent questionnaires
42 2, were examined using the national veterans affairs Clinical Assessment Reporting and Tracking (CART
45 -to-treat cohort analysis using the Veterans Affairs Clinical Case Registry to identify HIV/HCV GT1-c
47 med a retrospective cohort using the Veteran Affairs Clinical Case Registry, which contains nationwid
48 eterization, including 12232 in the Veterans Affairs cohort between October 1, 2007, and September 30
49 ectious Diseases Society of America Clinical Affairs Committee has long endeavored to quantify the va
51 ween July 2002 and June 2011 at the Veterans Affairs Connecticut Healthcare System were included in t
52 ement (ADAM) study conducted by the Veterans Affairs Cooperative Studies Program from 1992 to 2000.
53 tments such as the US Department of Veterans Affairs Cooperative Studies Program have also enhanced t
54 revention Study (SPS; Department of Veterans Affairs Cooperative Studies Program Number 403), SPS par
58 e database analysis of the national Veterans Affairs database for patients with a admission diagnosis
59 ection Agency and the Department of Veterans Affairs databases to build an observational cohort of 2,
60 ort of 760 men in the Department of Veterans Affairs Dental Longitudinal Study and Normative Aging St
61 d 29 to 64 years at entry) from the Veterans Affairs Dental Longitudinal Study from whom DNA and dent
62 ociation, as well as those from the Veterans Affairs/Department of Defense and the Joint British Soci
66 HIV care from the US Department of Veterans Affairs during 2009-2013 were evaluated to determine tre
68 istry of Health; Italian Ministry of Foreign Affairs; EMERGENCY's private donations; and Royal Engine
70 Male patients seen in the Miami Veterans Affairs eye clinic aged 50 years or older were recruited
71 etrospective cohort study involving Veterans Affairs facilities from January 1, 2000, to December 31,
72 Our hospital was one of the first Veterans Affairs facilities to launch a transcatheter aortic valv
73 safely and with good outcomes at a Veterans Affairs facility with a committed multidisciplinary team
74 in an EHR data warehouse at a large Veterans Affairs facility, and manual record reviews were used to
75 everse sequence algorithm (RSA) in a Veteran Affairs facility, finding 5.5% reactive Treponema pallid
76 ents who received warfarin from the Veterans Affairs from 2007 to 2008, International Classification
82 were enrolled in the Department of Veterans Affairs health care system between October 7, 2001, and
83 84 years with ASCVD treated in the Veterans Affairs health care system from April 1, 2013, to April
90 catheterization (2007-2012) in the Veterans Affairs healthcare system (n=21,727; 908-day median foll
93 We used the national Department of Veterans Affairs Hepatitis C Virus Clinical Case Registry to iden
94 V-infected veterans followed in the Veterans Affairs HIV Clinical Case Registry from 1996 to 2011.
96 -sectional study conducted at Miami Veterans Affairs Hospital included 118 individuals with a wide va
97 rt study at a university-affiliated Veterans Affairs hospital of all noncardiac surgical patients wit
98 ted to 15 intensive care units in a Veterans Affairs hospital setting (the Veterans Integrated Servic
99 , 2015, among patients at the Miami Veterans Affairs Hospital with a wide variety of dry eye symptoms
100 , 2015, among patients at the Miami Veterans Affairs Hospital with a wide variety of dry eye symptoms
102 surgeon-patient consultations) from Veteran Affairs hospitals and a randomized controlled laboratory
103 VG-PCI between 2008 and 2011 at all Veterans Affairs hospitals and compared clinical outcomes of betw
104 gery and were discharged alive from Veterans Affairs hospitals for orthopedic, general, and vascular
105 y included all patients admitted to Veterans Affairs hospitals from 2003 to 2010 who had positive blo
107 urgical procedures performed at 117 Veterans Affairs hospitals from 2007 to 2014 were identified, and
109 s of patients undergoing surgery in Veterans Affairs hospitals from October 1, 2008, through Septembe
111 ized clinical trial conducted at 18 Veterans Affairs hospitals using the Randomized On/Off Bypass (RO
112 ardiography registries from 2 major Veterans Affairs hospitals were accessed to identify patients wit
113 tive cohort study in patients at US Veterans Affairs hospitals who had a coronary stent placed betwee
114 to internal medicine services in 10 Veterans Affairs hospitals, end-of-rotation transition in care wa
118 who were ineligible for treatment (Veterans Affairs HR=2.35, CI 1.18-4.69, mean follow-up 10 years,
119 performed a retrospective study of Veterans Affairs Human Immunodeficiency Virus Clinical Case Regis
123 urrent delay and wait times prevent Veterans Affairs institutions from fully meeting the needs of cur
125 erformed secondary data analyses of Veterans Affairs intensive care unit (ICU) episodes across 5 year
126 cident AMI (Medicaid, Medicare, and Veterans Affairs International Classification of Diseases-9 codes
132 , OH, USA) and the US Department of Veterans Affairs, Louis Stokes Cleveland Veterans Affairs Medical
133 ty) estimated from responses to the Veterans Affairs Low Vision Visual Functioning Questionnaire (hig
134 ty) estimated from responses to the Veterans Affairs Low Vision Visual Functioning Questionnaire (hig
138 and December 31, 2012, at a single Veterans Affairs medical center among a consecutive cohort of 166
139 ronic medical records of a regional Veterans Affairs Medical Center and a pathologically confirmed Ba
140 endent cohorts from a United States Veterans Affairs Medical Center and a University Teaching Hospita
141 e disorder from the Ralph H Johnson Veterans Affairs Medical Center and four associated community out
142 ents who underwent primary TKA at a Veterans Affairs Medical Center before (March 3, 2013-March 2, 20
144 n segments total) at the West Haven Veterans Affairs Medical Center from January 2014 to February 201
145 bmitted to the IRB at a large urban Veterans Affairs medical center from June 1, 2009, through May 31
146 5 primary care clinics in a single Veterans Affairs medical center from June 2010 through May 2012,
147 h PTSD recruited at the Minneapolis Veterans Affairs Medical Center from March 2012 to December 2013.
148 munity-based clinics of the Atlanta Veterans Affairs Medical Center from October 1, 2008, through Mar
151 for the treatment of VRE-BSI among Veterans Affairs Medical Center patients admitted during 2004-201
152 onal Review Board and the Iowa City Veterans Affairs Medical Center Research and Development Committe
153 n January and September 2012 at the Veterans Affairs Medical Center Tennessee Valley Healthcare Syste
155 d all 9153 patients from a level 1b Veterans Affairs medical center who presented for major, elective
156 ermatology clinics of the affiliated Veteran Affairs medical center with biopsy-confirmed DN with pos
157 l Cancer Institute cancer center, a Veterans Affairs Medical Center, and community outreach clinics w
159 d and followed up at the Sacramento Veterans Affairs Medical Center, Mather, California, from March 5
160 nical Center (GRECC), Department of Veterans Affairs Medical Center, Tennessee Valley Healthcare Syst
161 r osteoarthritis in a Department of Veterans Affairs medical center, this study found no statisticall
175 resting conditions at academic and Veterans Affairs medical centers among 56 individuals in the foll
176 rtion skills checklist, we compared Veterans Affairs Medical Centers attending physicians' simulated
177 tients receiving coronary stents at Veterans Affairs medical centers between 2000 and 2010 was used t
178 s of pneumonia at 128 Department of Veterans Affairs medical centers from 2006 through 2010, we measu
179 ncluded dyslipidaemic veterans from Veterans Affairs Medical Centers in Palo Alto, CA, and Washington
180 e subjects (58.3+/-11 years) at the Veterans Affairs Medical Centers in Washington, DC, and Palo Alto
181 m managers from 51 US Department of Veterans Affairs medical centers to collect data on skin-related
184 ixty-seven patients hospitalized at Veterans Affairs medical centers were randomized to the surveilla
192 was estimated statistically by the Veterans Affairs mortality risk estimate and subjectively by card
194 -4 (ranging from 75% to 93%) in the Veterans Affairs national health care system achieved SVR12, appr
195 All patients identified in the Veterans Affairs National Surgical Quality Improvement Program da
197 July 2011 to September 2015 at the Veterans Affairs Nebraska-Western Iowa Heath Care System, a Level
198 included 370 participants from the Veterans Affairs Normative Aging Study with up to 2 visits betwee
201 luded 839 participants from the VA (Veterans Affairs) Normative Aging Study whose lung function [forc
202 UK Government, Dutch Ministry of Foreign Affairs, Norwegian Agency for Development Cooperation, T
204 with and without glaucoma from the Veterans Affairs Ophthalmic Surgical Outcomes Data Project were c
205 ical quality improvement databases (Veterans Affairs or American College of Surgeons National Surgica
207 terventional study performed at the Veterans Affairs Palo Alto Health Care System, patients 35 years
208 pective cohort study using national Veterans Affairs patient-level data on adherence to the original
209 ective cohort study of hospitalized Veterans Affairs patients treated with standard-dose (6 mg/kg tot
210 pregnancy and patient safety and regulatory affairs personnel to meet serious adverse event reportin
211 ed a retrospective case series in a Veterans Affairs population from 1991 to 2013 to characterize blu
212 h moderate-to-severe knee OA from 3 Veterans Affairs primary care clinics were enrolled in a randomiz
213 010 to June 2011 for 964 818 active Veterans Affairs primary care patients >/=18 years of age with di
218 R01HL108441-01A1) and Department of Veterans Affairs Sierra Pacific Mental Illness Research, Educatio
219 esearch (AACR) Science Policy and Government Affairs (SPGA) Committee and American Society of Clinica
221 e patients, we linked 2785 to local Veterans Affairs Surgeons National Surgical Quality Improvement P
223 tudy of 266,101 patients within the Veterans Affairs Surgical Quality Improvement Program (2000-2014)
226 retrospective observational study, Veterans Affairs Surgical Quality Improvement Program data for su
229 m September 2014 to April 2015, the Veterans Affairs Surgical Quality Improvement Program database an
230 rospective cohort study of national Veterans Affairs Surgical Quality Improvement Program preoperativ
234 rontieres; the Norwegian Ministry of Foreign Affairs through the Research Council of Norway; and the
235 ns Frontieres, Norwegian Ministry of Foreign Affairs (through the Research Council of Norway's GLOBVA
236 prior reviews have attributed this state of affairs to diagnostic heterogeneity, symptom comorbidity
237 y care clinics in the Department of Veterans Affairs to indicate a positive screen, the 4-item PC-PTS
238 ection Agency and the Department of Veterans Affairs, to build a cohort of US veterans, and used surv
239 on comprising 1,131 veterans in the Veterans Affairs Topical Tretinoin Chemoprevention (VATTC) Trial.
244 re study sites, fewer university or Veterans Affairs treatment settings, and a lower percentage of pa
246 a's Ministry for Health, Welfare, and Family Affairs, UK Wellcome Trust, Wolfson Foundation, UK Strok
247 ied Research Program, and Ann Arbor Veterans Affairs/University of Michigan Patient Safety Enhancemen
248 ve cohort study using data from the Veterans Affairs VA hepatitis C virus (HCV) Clinical Case Registr
249 out comparative performance between Veterans Affairs (VA) and non-VA hospitals, particularly related
252 April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) ap
255 who underwent bariatric surgery in Veterans Affairs (VA) bariatric centers from 2000-2011 and matche
256 ements incurred $1.4 million in non-Veterans Affairs (VA) care costs with an average length of stay o
257 by using the national Department of Veterans Affairs (VA) Central Cancer Registry (2004-2007) and lin
259 S AND Using a multicenter, national Veterans Affairs (VA) cohort, all patients who underwent cardiac,
260 ere recruited from 11 Department of Veterans Affairs (VA) community-based outpatient clinics serving
261 Using data from the Department of Veterans Affairs (VA) Corporate Warehouse Data from 2015, we eval
262 uded the 1,152 dentate males in the Veterans Affairs (VA) Dental Longitudinal Study who presented for
265 d with HIV who received care in the Veterans Affairs (VA) health care system nationally between 1996
270 ) study from the U.S. Department of Veterans Affairs (VA) healthcare system, we identified patients w
271 ber 28,2012 in any Department of US Veterans Affairs (VA) hospital, we identified 5,968 with availabl
272 ures performed at 112 Department of Veterans Affairs (VA) hospitals found an overall complication rat
274 nance dialysis in the Department of Veterans Affairs (VA) in fiscal years 2000-2009 (n=1691) to chara
277 cohort study in a tertiary referral Veterans Affairs (VA) medical center within an 8-state designated
279 e 1990s after implementation of the Veterans Affairs (VA) National Surgical Quality Improvement Progr
281 BE patients identified from national Veteran Affairs (VA) outpatient files, diagnosed with BE from 20
282 a national retrospective cohort of Veterans Affairs (VA) patients with the diagnosis of cirrhosis (n
285 Defense (DoD) and the Department of Veterans Affairs (VA) provide comprehensive HIV treatment and car
286 m the patients at the Department of Veterans Affairs (VA) sites and some non-VA sites in the United S
288 spective review of records from the Veterans Affairs (VA) Surgical Quality Improvement Program (VASQI
291 e Part D and the U.S. Department of Veterans Affairs (VA) use different approaches to manage prescrip
292 ejection fraction receiving care at Veterans Affairs (VA) versus non-VA hospitals have not been previ
296 uidelines and 2014 US Department of Veterans Affairs (VA)/US Department of Defense (DoD) joint clinic
297 rticipating in the US Department of Veterans Affairs Veterans Aging Cohort Study from April 1, 2003,
298 imary Funding Source: Department of Veterans Affairs, Veterans Health Administration, Office of Resea
299 VA Healthcare System, Department of Veterans Affairs, Veterans Health Administration, Office of Resea
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。